Joel Dudley, PhD Email Joel Dudley
- DIRECTOR, INSTITUTE FOR NEXT GENERATION HEALTHCARE
- ASSOCIATE PROFESSOR | Genetics and Genomic Sciences
- ASSOCIATE PROFESSOR | Population Health Science and Policy
- ASSOCIATE PROFESSOR | Medicine
Dr. Dudley is currently an Associate Professor of Genetics and Genomic Sciences and Icahn Institute for Data Science and Genomic Technology. Dr. Dudley is also Director of the Institute for Next Generation Healthcare at the Icahn School of Medicine at Mount Sinai. Prior to Mount Sinai, he held positions as Co-founder and Director of Informatics at NuMedii, Inc. and Consulting Professor of Systems Medicine in the Department of Pediatrics at Stanford University School of Medicine. His work is focused on developing and applying methods to integrate the digital universe of information to build better predictive models of disease, drug response, and scientific wellness. His work has been featured in the Wall Street Journal, Scientific American, and other popular media outlets, and he was named in 2014 as one of the 100 most creative people in business by Fast Company magazine. He is co-author of the book Exploring Personal Genomics from Oxford University Press. He received a BS in Microbiology from Arizona State University and an MS and PhD in Biomedical Informatics from Stanford University School of Medicine.
Bioinformatics, Computational Neuroscience, Epigenetics, Genetics, Human Genetics and Genetic Disorders
Multi-Disciplinary Training Areas
Genetics and Data Science [GDS], Neuroscience [NEU]
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Dudley during 2019 and/or 2020. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Thorne Research
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Onegevity Health
Scientific Advisory Board:
- AI Therapeutics
- Ayasdi, Inc.
- Onegevity Health
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.